Esperion Therapeutics Inc (ESPR)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 447.6M
P/E Ratio
0.00
Revenue (TTM)
$ 268.12M
Volume
0
52W High
$ 3.94
52W Low
$ 0.69
Dividend Yield
0.00%
Beta
0.82
Technicals
50-Day MA
1.5224
200-Day MA
1.657
52 Week High
3.94
52 Week Low
0.6925
About ESPR
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United State.
Employees
304
Headquarters
Ann Arbor, MI
CEO
Mr. Sheldon L. Koenig